To directly compare effects of anti–PD-1 antibody therapy on tumor growth, we orthotopically implanted either EO771 or AT-3 breast cancer cells with syngeneic immortalized mouse mammary fibroblasts. The gene discussed is PDCD1; the disease is breast carcinoma.